Skip to main content
Top
Published in: Current Rheumatology Reports 2/2012

Open Access 01-04-2012 | CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Association Between Gout and All-Cause as well as Cardiovascular Mortality: A Systematic Review

Authors: Kathrin Lottmann, Xiaoyu Chen, Peter K. Schädlich

Published in: Current Rheumatology Reports | Issue 2/2012

Login to get access

Abstract

Gout affects 1% to 2% of the population, and the prevalence is increasing due to changes in diet and the ageing of the population. Its development and risk factors have been explored frequently, and recommendations for the diagnosis and management of gout implemented. Nevertheless, there is a lack of knowledge regarding the long-term impact on gouty patients. This systematic review therefore evaluates the association between gout and all-cause as well as cardiovascular mortality. A systematic literature search was performed, and seven long-term studies were ultimately analyzed. Six of them used multivariate regressions to assess the adjusted mortality ratio in gouty patients with reference to patients without the disorder. Despite differences in study designs, study populations, and definitions of gout, the results were consistent: There was an independent association between gout and all-cause as well as cardiovascular mortality. Knowing that patients with gout are at risk emphasizes the need for adequate care.
Literature
1.
go back to reference Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1301–11.PubMedCrossRef Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1301–11.PubMedCrossRef
2.
3.
go back to reference Tausche AK, Jansen TL, Schröder HE, et al. Gout – current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:549–55.PubMed Tausche AK, Jansen TL, Schröder HE, et al. Gout – current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:549–55.PubMed
4.
go back to reference Gresser U. Diagnosis and therapy of gout. Dtsch Artzebl. 2003;100:2862–70. Gresser U. Diagnosis and therapy of gout. Dtsch Artzebl. 2003;100:2862–70.
5.
go back to reference Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout—a systematic review. Rheumatology. 2006;45:1422–31.CrossRef Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout—a systematic review. Rheumatology. 2006;45:1422–31.CrossRef
6.
go back to reference Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.PubMedCrossRef Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.PubMedCrossRef
7.
8.
go back to reference Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008;67:960–6.PubMedCrossRef Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008;67:960–6.PubMedCrossRef
9.
go back to reference Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–24.PubMedCrossRef Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–24.PubMedCrossRef
10.
go back to reference Rider TG, Jordan KM. The modern management of gout. Rheumatology. 2010;49:5–14. Erratum in: Rheumatology 2010, 49:830.PubMedCrossRef Rider TG, Jordan KM. The modern management of gout. Rheumatology. 2010;49:5–14. Erratum in: Rheumatology 2010, 49:830.PubMedCrossRef
11.
go back to reference Weselman KO, Agudelo CA. Is it gout? Tap the joint! J Med Assoc Ga. 2002;91:18–20.PubMed Weselman KO, Agudelo CA. Is it gout? Tap the joint! J Med Assoc Ga. 2002;91:18–20.PubMed
12.
go back to reference Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Atlanta, GA: Centers for Disease Control and Prevention. 2011 [updated 2011 Sep 23]. http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed Oct 2011. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Atlanta, GA: Centers for Disease Control and Prevention. 2011 [updated 2011 Sep 23]. http://​www.​cdc.​gov/​nchs/​icd/​icd9cm.​htm. Accessed Oct 2011.
15.
go back to reference Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1–173. Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1–173.
16.
go back to reference Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine: how to review and apply findings of healthcare rResearch. London: Royal Society of Medicine Press Ltd; 2003. Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine: how to review and apply findings of healthcare rResearch. London: Royal Society of Medicine Press Ltd; 2003.
17.
go back to reference DAHTA@DIMDI.de: [Methodological requirements for preparing an HTA-report]. Cologne: German Institute for Medical Documentation and Information, n.a. DAHTA@DIMDI.de: [Methodological requirements for preparing an HTA-report]. Cologne: German Institute for Medical Documentation and Information, n.a.
18.
go back to reference Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:163–94. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:163–94.
19.
go back to reference Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310–6.PubMedCrossRef Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310–6.PubMedCrossRef
20.
go back to reference Abbott KC, Kimmel PL, Dharnidharka V, et al. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80:1383–91.PubMedCrossRef Abbott KC, Kimmel PL, Dharnidharka V, et al. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80:1383–91.PubMedCrossRef
21.
go back to reference Cohen SD, Kimmel PL, Neff R, et al. Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol. 2008;19:2204–10.PubMedCrossRef Cohen SD, Kimmel PL, Neff R, et al. Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol. 2008;19:2204–10.PubMedCrossRef
22.
go back to reference ••Thanassoulis G, Brophy JM, Richard H, Piloe L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010; 170:1358–64. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause mortality. PubMedCrossRef ••Thanassoulis G, Brophy JM, Richard H, Piloe L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010; 170:1358–64. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause mortality. PubMedCrossRef
23.
go back to reference Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008;168:1104–10.PubMedCrossRef Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008;168:1104–10.PubMedCrossRef
24.
go back to reference Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894–900.PubMedCrossRef Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894–900.PubMedCrossRef
25.
go back to reference ••Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology. 2010; 49:141–6. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause as well as cardiovascular mortality. PubMedCrossRef ••Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology. 2010; 49:141–6. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause as well as cardiovascular mortality. PubMedCrossRef
26.
go back to reference Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41:237–42.PubMedCrossRef Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41:237–42.PubMedCrossRef
27.
go back to reference Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54:2688–96.CrossRef Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54:2688–96.CrossRef
28.
go back to reference Nishioka K, Mikanagi K. A retrospective study on the cause of death, in Japan, of patients with gout. Ryumachi. 1981;21:29–33.PubMed Nishioka K, Mikanagi K. A retrospective study on the cause of death, in Japan, of patients with gout. Ryumachi. 1981;21:29–33.PubMed
29.
go back to reference Nishioka N, Mikanagi K. Clinical features of 4,000 gouty subjects in Japan. Adv Exp Med Biology. 1980;122A:47–54. Nishioka N, Mikanagi K. Clinical features of 4,000 gouty subjects in Japan. Adv Exp Med Biology. 1980;122A:47–54.
30.
go back to reference Wijands JMA, Boonen A, Arts ICW, et al. Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria. Curr Rheumatol Rep. 2011;13:167–74.CrossRef Wijands JMA, Boonen A, Arts ICW, et al. Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria. Curr Rheumatol Rep. 2011;13:167–74.CrossRef
Metadata
Title
Association Between Gout and All-Cause as well as Cardiovascular Mortality: A Systematic Review
Authors
Kathrin Lottmann
Xiaoyu Chen
Peter K. Schädlich
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Rheumatology Reports / Issue 2/2012
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-011-0234-2

Other articles of this Issue 2/2012

Current Rheumatology Reports 2/2012 Go to the issue

PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

Granulomatosis with Polyangiitis in Childhood

PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

Pediatric Vasculitis

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Regulation of Uric Acid Excretion by the Kidney

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

The Patient’s Experience of Gout: New Insights to Optimize Management

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.